6th World Parkinson Congress

Can the Genetics of Sporadic PD and DLB Help in Disease Subtyping? What Could be the Therapeutic Implications?

By 6th World Parkinson Congress FEATURING Sonja Scholz

97 views

August 29, 2023

Comments 0

Plenary Sessions

The Role of Alpha-Synuclein and Co-Pathology in Cognitive and Non-Mo…

6th World Parkinson Congress

G. Aldridge

26 views

Co-Pathologies and Parkinson’s: What’s it All Mean to Those Living W…

6th World Parkinson Congress

S. Mathur

6 views

Prevalence of Co-Pathologies in Parkinson’s Disease

6th World Parkinson Congress

L. Walker

64 views

Contributions of Co-Pathologies in Activating the Immune Response in…

6th World Parkinson Congress

A. Harms

34 views

How Can Imaging Track PD?

6th World Parkinson Congress

T. Van Eimeren

106 views

Self-Tracking: To Track or Not to Track?

6th World Parkinson Congress

S. Riggare

63 views

Why Should we Track Parkinson’s Disease?

6th World Parkinson Congress

B. R. Bloem

389 views

How Can We Track PD Using Blood and Tissue-Based Biomarkers?

6th World Parkinson Congress

D. Standaert

118 views

Best Options for Nutrition in Parkinson’s

6th World Parkinson Congress

S. Appel-Cresswell

130 views

What do Subtypes Mean for People with Parkinson’s?

6th World Parkinson Congress

J. Acheson

10 views

Different α-synuclein Strains in Parkinson’s Disease Brains

6th World Parkinson Congress

M. Zweckstetter

65 views

Can the Genetics of Sporadic PD and DLB Help in Disease Subtyping? W…

6th World Parkinson Congress

S. Scholz

97 views

Brain-First vs. Body-First Parkinson’s Disease

6th World Parkinson Congress

P. Borghammer

118 views